Friday, May 20, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Severe COVID linked to RAAS and hyperlipidemia associated metabolic syndrome conditions

by Medical Finance
in Coronavirus
Renin–angiotensin–aldosterone system. Image Credit: Designua / Shutterstock
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

A recent study posted to the medRxiv* preprint server investigated the association of renin-angiotensin-aldosterone system (RAAS)-mediated hypertension (HT) with coronavirus disease 2019 (COVID-19).

Various studies have reported the role of angiotensin-converting enzyme-2 (ACE-2) receptors as the point of entry for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This information makes the ACE-2 receptors a critical focus in the assessment of RAAS-mediated hypertension and COVID-19 severity.

Renin–angiotensin–aldosterone system. Image Credit: Designua / ShutterstockRenin–angiotensin–aldosterone system. Image Credit: Designua / Shutterstock

About the study

In the present study, researchers explored the physiology of risk factors related to the impact of COVID-19 on RAAS-targeted HT drugs and the interactions of hyperlipidemia (HL) with other risk factors associated with severe COVID-19.

The team collected data from electronic health records obtained from emergency and clinical health services and insurance records. The extracted records were classified into different sets based on several measures.

Out of the 1,000,000 randomly selected samples, approximately 997,140 were eligible for the study. However, the final study cohort included 269,536 COVID-19 patients plus an equal number of individuals who were not diagnosed with COVID-19, totaling 539,523 participants.

Two sample cohorts were drawn from the Explorys system: a random sample and all C19 patients plus an equal-sized randomly selected non-C19 control group. The total counts indicate the number after dropping missing entries. Abbreviations include Alzheimer’s disease (AD), hypertension (HT), chronic kidney disease (CKD), hyperlipidemia (HL), cardiovascular disease (CVD), type 2 diabetes (T2D), pulmonary edema (PE), beta-blocker (BB), calcium channel blocker (CCB), African Americans (AfAm).

Two sample cohorts were drawn from the Explorys system: a random sample and all C19 patients plus an equal-sized randomly selected non-C19 control group. The total counts indicate the number after dropping missing entries. Abbreviations include Alzheimer’s disease (AD), hypertension (HT), chronic kidney disease (CKD), hyperlipidemia (HL), cardiovascular disease (CVD), type 2 diabetes (T2D), pulmonary edema (PE), beta-blocker (BB), calcium channel blocker (CCB), African Americans (AfAm).

The team evaluated the impact of the RAAS hypertension pathway on manifestations of severe COVID-19 by analyzing the interaction of HT with RAAS drugs, including ACE inhibitors and angiotensin receptor blockers (ARBs), and comparing these interactions with non-RAAS medications like beta-blockers and calcium channel blockers.

Redescription-based topological data analysis (RTDA) was performed using phenotypic combinations that could distinguish underlying biological processes and related pathways. The team applied computation homology to determine topological loops found among the pathways. The collections of deformed simplices found in these loops represented connected redescriptions. Such redescriptions were organized into homology groups to obtain more information about the complex disease processes. The team also applied persistent homology analysis to examine homology groups. The representative cycles were subsequently used to characterize relevant redescriptions as markers for homological cycles.

The team performed cumulant-based network analysis (CuNA) and extracted data on associations between RAAS drugs, COVID-19 manifestations, age, gender, and susceptibility to COVID-19 infection and severity. Homological cycles were selected to highlight inclusions that involved severe COVID-19 and three types of HT drugs, viz. ACE inhibitors, beta-blockers, and ARBs.

Results

The study results showed that among the two sample sets extracted, the random cohort comprised 997,140 individuals, the COVID-19-infected cohort comprised 269,536 patients, and the control group comprised 269,987 individuals.

The team found a strong association between HT and severe COVID-19. Additionally, distinctive metabolic syndrome features were observed among the study populations, including susceptibility to HT drugs, type 2 diabetes, and subsequent kidney failure. In these populations, calcium channel blockers were the primary choice of medicines for HT treatment, whereas RAAS drugs were not used often by severe COVID-19 patients.

The homological cycles indicated that HL posed a risk factor among patients diagnosed with severe COVID-19. In contrast, logistic regressions (LR) did not determine the first-order association between HL and COVID-19 severity. Also, LR predicted the presentation of severe COVID-19 only in the infected cohort treated with ARBs and ACE-inhibitors. This indicated that hyperlipidemia was not a critical risk factor for severe COVID-19 patients.

Moreover, the team found that hyperlipidemia substantially reduced the effect of other metabolic syndrome conditions on COVID-19 severity. Hyperlipidemia also lowered the impact of other factors, including being a male, being aged 65 years or above, or the presence of underlying conditions such as hypertension, pulmonary edema, and chronic kidney disease during the year of experiencing severe COVID-19, along with obesity, and type 2 diabetes. The authors noted that only the presentation of a cardiovascular disease aggravated COVID-19 severity.

Network representing higher-order significant interactions between different features with nodes colored by their relative rank (gradient of brown to green corresponds to higher to lower rank) and edges colored by their respective pairwise ORs (gradient of light to dark corresponds to low to high OR) and edge width indicates the strength of the connection between them. The communities obtained from this network are marked by dashed lines.

Network representing higher-order significant interactions between different features with nodes colored by their relative rank (gradient of brown to green corresponds to higher to lower rank) and edges colored by their respective pairwise ORs (gradient of light to dark corresponds to low to high OR) and edge width indicates the strength of the connection between them. The communities obtained from this network are marked by dashed lines.

Conclusion

The study findings showed that the RAAS complex played an important role in the exacerbation of chronic kidney disease in severe COVID-19 patients. The team also noted a trend that indicated that RAAS drugs suppressed the correlation of hypertension with severe COVID-19 more significantly than non-RAAS drugs. Furthermore, the researchers believe that this study highlighted the potential of topological data analysis in developing epidemiological studies that can efficiently target specific relationships to reveal novel connections that traditional analyses cannot fathom.

*Important notice

medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Heterologous immunization with inactivated vaccine followed by mRNA booster elicits strong humoral and cellular immune responses against the SARS-CoV-2 Omicron variant. Image Credit: Teeradej/Shutterstock

Study finds heterologous vaccine booster evokes robust immunity to SARS-CoV-2 Omicron variant

by Medical Finance
May 20, 2022
0

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that emerged in the last month of 2019 has undergone several...

Study: Durability and cross-reactivity of SARS-CoV-2 mRNA vaccine in adolescent children. Image Credit: Prostock-studio / Shutterstock.com

Study confirms waning immunity in adolescents following two doses of mRNA COVID-19 vaccines

by Medical Finance
May 20, 2022
0

In a recent study published on the medRxiv* preprint server, a team of researchers tested the durability of antibodies produced...

Study: Covariant Fitness Clusters Reveal Structural Evolution of SARS-CoV-2 Polymerase Across the Human Population. Image Credit: Naeblys/Shutterstock

Analyzing the evolution of SARS-CoV-2 RNA polymerase in humans

by Medical Finance
May 20, 2022
0

A recent work posted by researchers to the bioRxiv* preprint server investigated the evolutionary aspects of severe acute respiratory syndrome...

Study: Demonstration of Hollow Fiber Membrane-Based Enclosed Space Air Remediation for Capture of an Aerosolized Synthetic SARS-CoV-2 Mimic and Pseudovirus Particles. Image Credit: NokkieVector / Shutterstock.com

Hollow fiber membranes efficiently remove synthetic SARS-CoV-2 from the air

by Medical Finance
May 20, 2022
0

Airborne transmission is considered one of the primary factors contributing to the spread of the severe acute respiratory syndrome coronavirus...

Study: Development of the one-step qualitative RT-PCR assay to detect SARS-CoV-2 Omicron (B.1.1.529) variant in respiratory specimens. Image Credit: anyaivanova/Shutterstock

Single-step RT-PCR for SARS-CoV-2 Omicron variant detection in respiratory samples

by Medical Finance
May 20, 2022
0

A new preprint describes a single-step molecular diagnostic test for the presence of severe acute respiratory syndrome coronavirus 2...

Study: Modeling COVID-19 Vaccine Breakthrough Infections in Highly Vaccinated Israel - the effects of waning immunity and third vaccination dose. Image Credit: NEW-LIGHT-VISUALS / Shutterstock.com

Analysis of COVID vaccine breakthrough infections in highly vaccinated Israel

by Medical Finance
May 20, 2022
0

In a recent study published on the medRxiv* preprint server, researchers evaluated and modeled age-structured cases of severe acute respiratory...

Next Post
E Coli

How could AI be used to predict infection outcomes?

Testing the Structural Studies Of Biopolymers with the CPMAS Cryoprobe

Testing the Structural Studies Of Biopolymers with the CPMAS Cryoprobe

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Tissue Engineering 620x480
    Study reveals new approach for engineering stable articular cartilage
  • Microscope and portable computer with microscopic image on observation table in modern laboratory anyaivanova M1 9f1869108bc64cabbd24e42721185585 620x480
    Quantum dots can quantify specific types of cells inside deep tissues of the body
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply